XML 26 R53.htm IDEA: XBRL DOCUMENT v3.20.1
Share-based payments (Tables)
12 Months Ended
Dec. 31, 2019
Share-based payments  
Schedule of movement in number of shares under share purchase payment plans

 

 

 

 

 

    

Number of Series A

 

 

    

shares 

 

Outstanding as of January 1st, 2017

 

618,048

*

Purchased during the year

 

547,310

 

Granted during the year

 

 —

 

Exercised/vested during the year

 

(345,270)

 

Forfeited during the year

 

 —

 

Outstanding as of December 31, 2017

 

820,088

*

Purchased during the year

 

3,208,115

 

Granted during the year

 

 —

 

Exercised/vested during the year

 

(353,457)

 

Forfeited during the year

 

(121,451)

 

Outstanding as of December 31, 2018

 

3,553,295

*

Purchased during the year

 

2,694,600

 

Granted during the year

 

 —

 

Exercised/vested during the year

 

(959,614)

 

Forfeited during the year

 

(173,090)

 

Outstanding as of December 31, 2019

 

5,115,191

*


* These shares are presented as treasury shares in the consolidated statement of financial position as of December 31, 2019, 2018 and 2017.

Schedule of weighted average assumptions used to estimate the fair market value of the MIP at the date of grant

 

 

 

 

 

    

2012

 

Dividend yield (%)

 

0.00

%

Volatility (%)

 

37.00

%

Risk—free interest rate (%)

 

5.96

%

Expected life of share options (years)

 

8.8

 

Exercise share price (in Mexican pesos Ps.)

 

5.31

 

Exercise multiple

 

1.1

 

Fair value of the stock at grant date

 

1.73

 

 

Schedule of movement in number of shares options and fixed exercise prices

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Total in

 

 

Number of share

 

Exercise price

 

thousands of

 

    

options 

    

in Mexican pesos 

    

Mexican pesos 

Outstanding as of December 31, 2016

 

12,557,857

 

Ps.

5.31

 

Ps.

66,733

Granted during the year

 

 —

 

 

 —

 

 

 —

Forfeited during the year

 

 —

 

 

 —

 

 

 —

Exercised during the year

 

(120,000)

 

 

5.31

 

 

(638)

Outstanding as of December 31, 2017

 

12,437,857

 

Ps.

5.31

 

Ps.

66,095

Granted during the year

 

 —

 

 

 —

 

 

 —

Forfeited during the year

 

 —

 

 

 —

 

 

 —

Exercised during the year

 

(2,003,876)

 

 

5.31

 

 

(10,654)

Outstanding as of December 31, 2018

 

10,433,981

 

Ps.

5.31

 

Ps.

55,441

Granted during the year

 

 —

 

 

 —

 

 

 —

Forfeited during the year

 

 —

 

 

 —

 

 

 —

Exercised during the year

 

(2,780,000)

 

 

5.31

 

 

(14,773)

Outstanding as of December 31, 2019

 

7,653,981

 

Ps.

5.31

 

Ps.

40,668

 

Schedule of retention plan (benefit) expenses recognized

 

 

 

 

 

 

 

 

 

 

 

    

2019

    

2018

    

2017

(Benefit) expense arising from cash-settled share-based payments transactions

 

Ps.

40,724

 

Ps.

(5,238)

 

Ps.

(25,498)

Expense arising from equity-settled share-based payments transactions

 

 

49,659

 

 

19,980

 

 

13,508

Total expense (benefit) arising from share-based payments transactions

 

Ps.

90,383

 

Ps.

14,742

 

Ps.

(11,990)

 

Share purchase plan  
Share-based payments  
Schedule of vesting period of shares granted

 

 

 

Number of Series A

    

 

shares 

    

Vesting period 

2,211,269

 

November 2019 – 2020

2,005,716

 

November 2020 – 2021

898,206

 

November 2021 – 2022

5,115,191

 

  

 

SARs - cash settled  
Share-based payments  
Schedule of vesting period of shares granted

 

 

 

Number of SARs 

    

Exercisable date 

725,193

 

November 2020

 

 

 

725,193

*

  

 

MIP II  
Share-based payments  
Schedule of vesting period of shares granted

 

 

 

Number of SARs 

    

Vesting date

2,825,840

 

February 2020

3,391,020

 

February  2021

6,216,860

*  

  


* Includes forfeited SARs of 0,1,563,520 and 0, for the years ended December 31, 2019, 2018 and 2017, respectively.